COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 5.220 (1.960-13.920)
† |
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 1.890 (0.910-3.940)
† |
Zhang
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 1.950 (1.120-3.390)
† |
Ding
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 1.080 (0.900-1.290)
† |
Ding
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 2.380 (1.210-4.710)
† |
Sarkar
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 1.080 (0.410-2.890)
† |
Xu
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 2.730 (1.020-7.300)
|
Chen
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 3.430 (1.510-7.790)
† |
Wang
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 1.530 (0.780-3.010)
† |
Zhang
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 1.000 (0.400-2.530)
† |
Wang
|
|
|
COVID-19 (death) |
Comorbidities |
Chronic respiratory disease [Present vs. Not present] |
Hazard ratio: 1.100 (0.400-2.500)
|
Tian
|
|
|
COVID-19 (death) |
Comorbidities |
COPD [Present vs. Not present] |
Hazard ratio: 1.900 (0.900-3.900)
§ |
Tian
|
|
|
COVID-19 (death) |
Comorbidities |
COPD [Present vs. Not present] |
Hazard ratio: 2.600 (1.200-5.600)
|
Tian
|
|
|
COVID-19 (death) |
Comorbidities |
Diabetes [Present vs. Not present] |
Hazard ratio: 1.100 (0.700-1.900)
|
Tian
|
|
|
COVID-19 (death) |
Comorbidities |
Heart disease [Present vs. Not present] |
Hazard ratio: 3.000 (1.800-5.000)
§ |
Tian
|
|
|
COVID-19 (death) |
Comorbidities |
Heart disease [Present vs. Not present] |
Hazard ratio: 4.200 (2.500-7.100)
|
Tian
|
|
|